Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001698159 | SCV000526864 | likely benign | not provided | 2020-08-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000555745 | SCV000655430 | benign | Developmental and epileptic encephalopathy, 26 | 2024-12-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001698159 | SCV002064051 | likely benign | not provided | 2021-10-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003243123 | SCV003965987 | likely benign | Inborn genetic diseases | 2023-05-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001698159 | SCV005209947 | likely benign | not provided | criteria provided, single submitter | not provided |